CompaniesByCap
SPRO
Spero Therapeutics Inc. (SPRO)
NASDAQ · Healthcare

Spero Therapeutics Inc. Cash Flow 2016–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Operating Activities
Operating Cash Flow-12.6M-23.4M-33.0M-7.7M-64.3M-85.9M-50.0M-39.6M-39.1M-29.0M
Depreciation & Amort.02,000367,000869,000646,000761,000750,000409,000363,000279,000
Investing Activities
Capital Expenditure157,000314,0002.4M27,000830,000
Free Cash Flow-86.0M-50.3M-42.1M-39.1M-29.8M
Financing Activities
Dividends Paid
Stock Buybacks

Spero Therapeutics Inc. Cash Flow — FAQ

Spero Therapeutics Inc. (SPRO) cash flow over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see SPRO's cash flow history?

The chart and table above show Spero Therapeutics Inc.'s cash flow by year and by quarter, including the growth rate.